US Stock MarketDetailed Quotes

Alaunos Therapeutics (TCRT)

Watchlist
  • 2.810
  • +0.070+2.55%
Close Jan 15 16:00 ET
  • 2.870
  • +0.060+2.12%
Post 20:01 ET
6.27MMarket Cap-1.22P/E (TTM)

Alaunos Therapeutics (TCRT) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
15.15%1.94M
16.89%2.88M
-92.30%319K
-82.00%1.09M
-82.00%1.09M
-85.91%1.68M
-86.55%2.46M
-82.36%4.15M
-84.48%6.06M
-84.48%6.06M
-Cash and cash equivalents
15.15%1.94M
16.89%2.88M
-92.30%319K
-82.00%1.09M
-82.00%1.09M
-85.91%1.68M
-86.55%2.46M
-82.36%4.15M
-84.48%6.06M
-84.48%6.06M
Receivables
--0
-50.00%2K
100.00%2K
400.00%5K
400.00%5K
--0
0.00%4K
--1K
-75.00%1K
-75.00%1K
-Accounts receivable
--0
-50.00%2K
100.00%2K
400.00%5K
400.00%5K
--0
0.00%4K
--1K
-75.00%1K
-75.00%1K
Prepaid assets
----
----
--746K
----
----
----
----
----
----
----
Other current assets
-59.99%747K
-61.24%857K
----
-24.52%1.66M
-24.52%1.66M
101.84%1.87M
383.81%2.21M
152.13%1.89M
175.09%2.2M
175.09%2.2M
Total current assets
-24.37%2.69M
-20.09%3.74M
-82.33%1.07M
-66.65%2.76M
-66.65%2.76M
-72.41%3.55M
-75.09%4.68M
-84.19%6.04M
-84.64%8.26M
-84.64%8.26M
Non current assets
Net PPE
--97K
----
----
--0
--0
--0
--0
--0
-99.98%2K
-99.98%2K
-Gross PPE
----
----
----
0.00%15K
0.00%15K
----
----
----
-99.93%15K
-99.93%15K
-Accumulated depreciation
----
----
----
-15.38%-15K
-15.38%-15K
----
----
----
99.87%-13K
99.87%-13K
Non current prepaid assets
----
----
--1.05M
----
----
----
----
----
----
----
Other non current assets
--942K
--997K
----
----
----
----
----
----
----
----
Total non current assets
--1.04M
--997K
--1.05M
--0
--0
--0
--0
--0
-99.98%2K
-99.98%2K
Total assets
4.90%3.72M
1.22%4.74M
-64.88%2.12M
-66.66%2.76M
-66.66%2.76M
-81.74%3.55M
-83.25%4.68M
-87.59%6.04M
-87.28%8.26M
-87.28%8.26M
Liabilities
Current liabilities
Payables
84.06%843K
121.64%809K
39.20%831K
-16.23%516K
-16.23%516K
-64.71%458K
-75.32%365K
-56.74%597K
-55.65%616K
-55.65%616K
-accounts payable
84.06%843K
121.64%809K
39.20%831K
-16.23%516K
-16.23%516K
-64.71%458K
-75.32%365K
-56.74%597K
-55.65%616K
-55.65%616K
Current accrued expenses
-78.80%78K
-51.11%265K
-64.07%231K
-86.43%176K
-86.43%176K
-88.02%368K
-83.24%542K
-84.39%643K
-69.80%1.3M
-69.80%1.3M
Current liabilities
11.50%921K
18.41%1.07M
-14.35%1.06M
-64.62%692K
-64.62%692K
-82.34%826K
-82.05%907K
-92.73%1.24M
-91.91%1.96M
-91.91%1.96M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
11.50%921K
18.41%1.07M
-14.35%1.06M
-64.62%692K
-64.62%692K
-85.09%826K
-85.55%907K
-93.52%1.24M
-92.59%1.96M
-92.59%1.96M
Shareholders'equity
Share capital
0.00%2K
0.00%2K
-87.50%2K
0.00%2K
0.00%2K
-99.17%2K
-99.17%2K
-93.36%16K
-87.50%2K
-87.50%2K
-common stock
0.00%2K
0.00%2K
-87.50%2K
0.00%2K
0.00%2K
-99.17%2K
-99.17%2K
-93.36%16K
-87.50%2K
-87.50%2K
-Preferred stock
--0
--0
----
----
----
----
----
----
----
----
Retained earnings
-0.44%-923.73M
-0.43%-922.57M
-0.44%-921.52M
-0.51%-920.45M
-0.51%-920.45M
-1.30%-919.7M
-2.13%-918.58M
-3.01%-917.45M
-3.99%-915.77M
-3.99%-915.77M
Paid-in capital
0.44%926.53M
0.42%926.23M
0.04%922.58M
0.05%922.51M
0.05%922.51M
0.09%922.43M
0.16%922.35M
0.25%922.23M
0.32%922.07M
0.32%922.07M
Total stockholders'equity
2.90%2.8M
-2.92%3.66M
-77.94%1.06M
-67.29%2.06M
-67.29%2.06M
-80.40%2.72M
-82.58%3.77M
-83.74%4.8M
-83.64%6.31M
-83.64%6.31M
Total equity
2.90%2.8M
-2.92%3.66M
-77.94%1.06M
-67.29%2.06M
-67.29%2.06M
-80.40%2.72M
-82.58%3.77M
-83.74%4.8M
-83.64%6.31M
-83.64%6.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 15.15%1.94M16.89%2.88M-92.30%319K-82.00%1.09M-82.00%1.09M-85.91%1.68M-86.55%2.46M-82.36%4.15M-84.48%6.06M-84.48%6.06M
-Cash and cash equivalents 15.15%1.94M16.89%2.88M-92.30%319K-82.00%1.09M-82.00%1.09M-85.91%1.68M-86.55%2.46M-82.36%4.15M-84.48%6.06M-84.48%6.06M
Receivables --0-50.00%2K100.00%2K400.00%5K400.00%5K--00.00%4K--1K-75.00%1K-75.00%1K
-Accounts receivable --0-50.00%2K100.00%2K400.00%5K400.00%5K--00.00%4K--1K-75.00%1K-75.00%1K
Prepaid assets ----------746K----------------------------
Other current assets -59.99%747K-61.24%857K-----24.52%1.66M-24.52%1.66M101.84%1.87M383.81%2.21M152.13%1.89M175.09%2.2M175.09%2.2M
Total current assets -24.37%2.69M-20.09%3.74M-82.33%1.07M-66.65%2.76M-66.65%2.76M-72.41%3.55M-75.09%4.68M-84.19%6.04M-84.64%8.26M-84.64%8.26M
Non current assets
Net PPE --97K----------0--0--0--0--0-99.98%2K-99.98%2K
-Gross PPE ------------0.00%15K0.00%15K-------------99.93%15K-99.93%15K
-Accumulated depreciation -------------15.38%-15K-15.38%-15K------------99.87%-13K99.87%-13K
Non current prepaid assets ----------1.05M----------------------------
Other non current assets --942K--997K--------------------------------
Total non current assets --1.04M--997K--1.05M--0--0--0--0--0-99.98%2K-99.98%2K
Total assets 4.90%3.72M1.22%4.74M-64.88%2.12M-66.66%2.76M-66.66%2.76M-81.74%3.55M-83.25%4.68M-87.59%6.04M-87.28%8.26M-87.28%8.26M
Liabilities
Current liabilities
Payables 84.06%843K121.64%809K39.20%831K-16.23%516K-16.23%516K-64.71%458K-75.32%365K-56.74%597K-55.65%616K-55.65%616K
-accounts payable 84.06%843K121.64%809K39.20%831K-16.23%516K-16.23%516K-64.71%458K-75.32%365K-56.74%597K-55.65%616K-55.65%616K
Current accrued expenses -78.80%78K-51.11%265K-64.07%231K-86.43%176K-86.43%176K-88.02%368K-83.24%542K-84.39%643K-69.80%1.3M-69.80%1.3M
Current liabilities 11.50%921K18.41%1.07M-14.35%1.06M-64.62%692K-64.62%692K-82.34%826K-82.05%907K-92.73%1.24M-91.91%1.96M-91.91%1.96M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 11.50%921K18.41%1.07M-14.35%1.06M-64.62%692K-64.62%692K-85.09%826K-85.55%907K-93.52%1.24M-92.59%1.96M-92.59%1.96M
Shareholders'equity
Share capital 0.00%2K0.00%2K-87.50%2K0.00%2K0.00%2K-99.17%2K-99.17%2K-93.36%16K-87.50%2K-87.50%2K
-common stock 0.00%2K0.00%2K-87.50%2K0.00%2K0.00%2K-99.17%2K-99.17%2K-93.36%16K-87.50%2K-87.50%2K
-Preferred stock --0--0--------------------------------
Retained earnings -0.44%-923.73M-0.43%-922.57M-0.44%-921.52M-0.51%-920.45M-0.51%-920.45M-1.30%-919.7M-2.13%-918.58M-3.01%-917.45M-3.99%-915.77M-3.99%-915.77M
Paid-in capital 0.44%926.53M0.42%926.23M0.04%922.58M0.05%922.51M0.05%922.51M0.09%922.43M0.16%922.35M0.25%922.23M0.32%922.07M0.32%922.07M
Total stockholders'equity 2.90%2.8M-2.92%3.66M-77.94%1.06M-67.29%2.06M-67.29%2.06M-80.40%2.72M-82.58%3.77M-83.74%4.8M-83.64%6.31M-83.64%6.31M
Total equity 2.90%2.8M-2.92%3.66M-77.94%1.06M-67.29%2.06M-67.29%2.06M-80.40%2.72M-82.58%3.77M-83.74%4.8M-83.64%6.31M-83.64%6.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More